US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ARGX

argenx (ARGX)

argenx SE

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARGX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/22	05 : 50	GlobeNewswire Inc.	argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy	NASDAQ:ARGX	argenx SE
2024/06/17	19 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/06/17	14 : 00	GlobeNewswire Inc.	argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024	NASDAQ:ARGX	argenx SE
2024/06/04	14 : 00	GlobeNewswire Inc.	argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:ARGX	argenx SE
2024/05/09	20 : 06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/05/09	14 : 00	GlobeNewswire Inc.	argenx Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ARGX	argenx SE
2024/05/08	19 : 15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/05/08	06 : 30	GlobeNewswire Inc.	argenx announces results of Annual General Meeting of Shareholders	NASDAQ:ARGX	argenx SE
2024/05/07	14 : 00	GlobeNewswire Inc.	argenx to Present at BofA Securities 2024 Health Care Conference	NASDAQ:ARGX	argenx SE
2024/05/02	14 : 00	GlobeNewswire Inc.	argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024	NASDAQ:ARGX	argenx SE
2024/04/16	14 : 00	GlobeNewswire Inc.	argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease	NASDAQ:ARGX	argenx SE
2024/03/27	15 : 00	GlobeNewswire Inc.	argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease	NASDAQ:ARGX	argenx SE
2024/03/27	05 : 00	GlobeNewswire Inc.	argenx Announces Annual General Meeting of Shareholders on May 7, 2024	NASDAQ:ARGX	argenx SE
2024/03/26	15 : 00	GlobeNewswire Inc.	argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia	NASDAQ:ARGX	argenx SE
2024/03/08	20 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/03/08	06 : 01	GlobeNewswire Inc.	argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting	NASDAQ:ARGX	argenx SE
2024/03/01	06 : 04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/02/29	15 : 00	GlobeNewswire Inc.	argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update	NASDAQ:ARGX	argenx SE
2024/02/26	15 : 00	GlobeNewswire Inc.	argenx to Present at Upcoming Investor Conferences	NASDAQ:ARGX	argenx SE
2024/02/22	15 : 00	GlobeNewswire Inc.	argenx to Report Full Year 2023 Financial Results and Fourth Quarter Business Update on February 29, 2024	NASDAQ:ARGX	argenx SE
2024/02/20	20 : 06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/02/20	15 : 00	GlobeNewswire Inc.	argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART Hytrulo in Chronic Inflammatory Demyelinating Polyneuropathy	NASDAQ:ARGX	argenx SE
2024/01/18	20 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/01/18	15 : 00	GlobeNewswire Inc.	argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis	NASDAQ:ARGX	argenx SE
2024/01/08	20 : 06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/01/08	15 : 00	GlobeNewswire Inc.	argenx Highlights 2024 Strategic Priorities	NASDAQ:ARGX	argenx SE
2024/01/02	15 : 00	GlobeNewswire Inc.	argenx to Present at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:ARGX	argenx SE
2023/12/21	02 : 37	Dow Jones News	Argenx Down Nearly 26%, on Pace for Record Percent Decrease -- Data Talk	NASDAQ:ARGX	argenx SE
2023/12/20	20 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2023/12/20	15 : 00	GlobeNewswire Inc.	argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus	NASDAQ:ARGX	argenx SE

Showing the most relevant articles for your search:NASDAQ:ARGX

1 2 3 4 5 6 7 8 9 10 次へ >>

JP Morgan Chase

US Dollar vs Yen

Financial Select Sector

Bank of America

US Dollar vs Euro

BNP Paribas (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約